
Anna Pagonakis
Examiner (ID: 6985)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1614, 4173, 1609, 1628, OPET |
| Total Applications | 1238 |
| Issued Applications | 444 |
| Pending Applications | 73 |
| Abandoned Applications | 723 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5051893
[patent_doc_number] => 20070032438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Pharmaceutical compositions containing taxanes and methods for preparing the pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 11/194676
[patent_app_country] => US
[patent_app_date] => 2005-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3981
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20070032438.pdf
[firstpage_image] =>[orig_patent_app_number] => 11194676
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/194676 | Pharmaceutical compositions containing taxanes and methods for preparing the pharmaceutical compositions | Aug 1, 2005 | Abandoned |
Array
(
[id] => 6931858
[patent_doc_number] => 20050282893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Methods and compositions for using suramin, pentosan, polysulfate, telomerase antisense and telomerase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/193883
[patent_app_country] => US
[patent_app_date] => 2005-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22535
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282893.pdf
[firstpage_image] =>[orig_patent_app_number] => 11193883
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/193883 | Methods and compositions for using suramin, pentosan, polysulfate, telomerase antisense and telomerase inhibitors | Jul 28, 2005 | Abandoned |
Array
(
[id] => 5820047
[patent_doc_number] => 20060024360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof'
[patent_app_type] => utility
[patent_app_number] => 11/192439
[patent_app_country] => US
[patent_app_date] => 2005-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11479
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024360.pdf
[firstpage_image] =>[orig_patent_app_number] => 11192439
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/192439 | Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof | Jul 27, 2005 | Abandoned |
Array
(
[id] => 4872691
[patent_doc_number] => 20080199425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Sensitization of Immune System Against Haptenized Melanoma Antigens'
[patent_app_type] => utility
[patent_app_number] => 11/996753
[patent_app_country] => US
[patent_app_date] => 2005-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7785
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20080199425.pdf
[firstpage_image] =>[orig_patent_app_number] => 11996753
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/996753 | Sensitization of Immune System Against Haptenized Melanoma Antigens | Jul 27, 2005 | Abandoned |
Array
(
[id] => 5415828
[patent_doc_number] => 20090041715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Epothilone Combinations'
[patent_app_type] => utility
[patent_app_number] => 11/658357
[patent_app_country] => US
[patent_app_date] => 2005-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9052
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20090041715.pdf
[firstpage_image] =>[orig_patent_app_number] => 11658357
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/658357 | Epothilone Combinations | Jul 24, 2005 | Abandoned |
Array
(
[id] => 5074764
[patent_doc_number] => 20070014739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Compositions and methods for controlling biofilms and bacterial infections'
[patent_app_type] => utility
[patent_app_number] => 11/181556
[patent_app_country] => US
[patent_app_date] => 2005-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21362
[patent_no_of_claims] => 118
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20070014739.pdf
[firstpage_image] =>[orig_patent_app_number] => 11181556
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/181556 | Compositions and methods for controlling biofilms and bacterial infections | Jul 13, 2005 | Abandoned |
Array
(
[id] => 5769219
[patent_doc_number] => 20060019941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Analogs of benzoquinone-containing ansamycins and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/180314
[patent_app_country] => US
[patent_app_date] => 2005-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38314
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019941.pdf
[firstpage_image] =>[orig_patent_app_number] => 11180314
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/180314 | Analogs of benzoquinone-containing ansamycins and methods of use thereof | Jul 12, 2005 | Abandoned |
Array
(
[id] => 5010439
[patent_doc_number] => 20070280918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'Multitherapy Against Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/572068
[patent_app_country] => US
[patent_app_date] => 2005-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7609
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20070280918.pdf
[firstpage_image] =>[orig_patent_app_number] => 11572068
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/572068 | Multitherapy Against Cancer | Jul 11, 2005 | Abandoned |
Array
(
[id] => 6930832
[patent_doc_number] => 20050281867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Nitric oxide inducing agents'
[patent_app_type] => utility
[patent_app_number] => 11/177761
[patent_app_country] => US
[patent_app_date] => 2005-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5900
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20050281867.pdf
[firstpage_image] =>[orig_patent_app_number] => 11177761
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/177761 | Nitric oxide inducing agents | Jul 7, 2005 | Abandoned |
Array
(
[id] => 5739077
[patent_doc_number] => 20060009468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Method for treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/176852
[patent_app_country] => US
[patent_app_date] => 2005-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8055
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009468.pdf
[firstpage_image] =>[orig_patent_app_number] => 11176852
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/176852 | Method for treatment of cancer | Jul 6, 2005 | Abandoned |
Array
(
[id] => 5638102
[patent_doc_number] => 20060069076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'LXR/RXR-related methods and compositions'
[patent_app_type] => utility
[patent_app_number] => 11/172317
[patent_app_country] => US
[patent_app_date] => 2005-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6514
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20060069076.pdf
[firstpage_image] =>[orig_patent_app_number] => 11172317
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/172317 | LXR/RXR-related methods and compositions | Jun 28, 2005 | Abandoned |
Array
(
[id] => 7233850
[patent_doc_number] => 20050256134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glucose metabolic disorders'
[patent_app_type] => utility
[patent_app_number] => 11/159590
[patent_app_country] => US
[patent_app_date] => 2005-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9201
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256134.pdf
[firstpage_image] =>[orig_patent_app_number] => 11159590
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/159590 | Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glucose metabolic disorders | Jun 21, 2005 | Abandoned |
Array
(
[id] => 5801413
[patent_doc_number] => 20060035881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Use of targeted oxidative therapeutic formulation in endodontic treatment'
[patent_app_type] => utility
[patent_app_number] => 11/158514
[patent_app_country] => US
[patent_app_date] => 2005-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6587
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035881.pdf
[firstpage_image] =>[orig_patent_app_number] => 11158514
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/158514 | Use of targeted oxidative therapeutic formulation in endodontic treatment | Jun 21, 2005 | Abandoned |
Array
(
[id] => 4451263
[patent_doc_number] => 07964587
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-21
[patent_title] => 'Tocopherol and tocotrienol aerosols'
[patent_app_type] => utility
[patent_app_number] => 11/159917
[patent_app_country] => US
[patent_app_date] => 2005-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8189
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/964/07964587.pdf
[firstpage_image] =>[orig_patent_app_number] => 11159917
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/159917 | Tocopherol and tocotrienol aerosols | Jun 21, 2005 | Issued |
Array
(
[id] => 4676975
[patent_doc_number] => 20080214606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Methods for the Identification and Use of Compounds Suitable for the Treatment of Drug Resistant Cancer Cells'
[patent_app_type] => utility
[patent_app_number] => 11/629233
[patent_app_country] => US
[patent_app_date] => 2005-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 27686
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214606.pdf
[firstpage_image] =>[orig_patent_app_number] => 11629233
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/629233 | Methods for the Identification and Use of Compounds Suitable for the Treatment of Drug Resistant Cancer Cells | Jun 15, 2005 | Abandoned |
Array
(
[id] => 7250639
[patent_doc_number] => 20050272738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Combined treatment with oxaliplatin and an epidermal growth factor receptor kinase inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/145091
[patent_app_country] => US
[patent_app_date] => 2005-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13750
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272738.pdf
[firstpage_image] =>[orig_patent_app_number] => 11145091
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/145091 | Combined treatment with oxaliplatin and an epidermal growth factor receptor kinase inhibitor | Jun 2, 2005 | Abandoned |
Array
(
[id] => 7250635
[patent_doc_number] => 20050272737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Combined treatment with irinotecan and an epidermal growth factor receptor kinase inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/144855
[patent_app_country] => US
[patent_app_date] => 2005-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15353
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272737.pdf
[firstpage_image] =>[orig_patent_app_number] => 11144855
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/144855 | Combined treatment with irinotecan and an epidermal growth factor receptor kinase inhibitor | Jun 2, 2005 | Abandoned |
Array
(
[id] => 7250346
[patent_doc_number] => 20050272688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Combined treatment with gemcitabine and an epidermal growth factor receptor kinase inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/144952
[patent_app_country] => US
[patent_app_date] => 2005-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14751
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272688.pdf
[firstpage_image] =>[orig_patent_app_number] => 11144952
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/144952 | Combined treatment with gemcitabine and an epidermal growth factor receptor kinase inhibitor | Jun 2, 2005 | Abandoned |
Array
(
[id] => 5397320
[patent_doc_number] => 20090317383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'CANCER TREATMENT METHOD'
[patent_app_type] => utility
[patent_app_number] => 11/569878
[patent_app_country] => US
[patent_app_date] => 2005-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8360
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20090317383.pdf
[firstpage_image] =>[orig_patent_app_number] => 11569878
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/569878 | CANCER TREATMENT METHOD | Jun 2, 2005 | Abandoned |
Array
(
[id] => 6931808
[patent_doc_number] => 20050282843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Therapeutic applications of 2-substituted 4-heteroarylpyrimidines'
[patent_app_type] => utility
[patent_app_number] => 11/140136
[patent_app_country] => US
[patent_app_date] => 2005-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16310
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282843.pdf
[firstpage_image] =>[orig_patent_app_number] => 11140136
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/140136 | Therapeutic applications of 2-substituted 4-heteroarylpyrimidines | May 25, 2005 | Abandoned |